Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Olanzapine in Patients With Borderline Personality Disorder
This study has been completed.
Study NCT00091650. Last updated on July 21, 2006.
Information provided by Eli Lilly and Company
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Borderline Personality Disorder
Additional conditions recognized in this trial
Disease
Personality Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Interventions listed in this trial
Olanzapine
placebo
More general drug interventions related to this trial
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content